A team of biochemists at the University of California, Santa Cruz, has developed a faster way to identify molecules in the ...

By Bhanvi Satija and Pushkala Aripaka LONDON, Feb 4 (Reuters) - GSK's new CEO Luke Miels said on Wednesday that the drugmaker ...

SHANGHAI, Feb 9 (Reuters) - China's Innovent Biologics has struck a new deal with Eli Lilly to develop immunology and oncology drugs, under which the U.S. drugmaker will pay $350 million upfront and ...

Investor enthusiasm and evolving FDA pathways are accelerating rare disease drug development, with ultrarare conditions like ...

AI boosts efficiency in early, high-failure R&D, improving success rates and capital efficiency across biotech and pharma.

The Indian Pharmacopoeia Commission has signed memoranda with the Goa State Pharmacy Council, Quality Council of India, and ...

Replacing animal testing with alternate methodologies in preclinical drug trials holds potential for the development of ...

A groundbreaking multi-stakeholder report reveals that transitioning to Non-Animal Methods (NAMs) can reduce drug development ...

More than 100 million people in the United States suffer from metabolic dysfunction-associated steatotic liver disease (MASLD ...

A major step toward simpler drug development has been taken at the University of Gothenburg. In a new study, researchers have developed stable boron-fluorine compounds that make it possible to ...

Discusses Integrated Prefillable Syringe Systems to Streamline Drug Development and Reduce Complexity February ...

DS-9606 was supposed to be the first antibody-drug conjugate in Daiichi Sankyo’s line of anti-cancer assets to use a modified ...